GlobeNewsWire
23 Sept 2026, 00:54 UTC · 1h ago
Verdict
Headline takes no side. We score RDY −0.90 across two claims — strongly bearish.
−0.90strongly bearish
More negative than 90% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish · 1 new · 1 priced in
Pomerantz LLP is investigating whether Dr. Reddy's Laboratories and its officers engaged in securities fraud or unlawful business practices.
Newpress release dated Sept. 22, 2026
So whatLegal discovery processes could reveal internal communications regarding semaglutide failures, potentially leading to costly settlements or fines in 2027.
More negative than 78% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Dr. Reddy's reported first quarter fiscal 2027 EPS of $0.06, impacted by a ₹2.4 billion provision for out-of-specification semaglutide batches.
Priced inannounced July 22, 2026
So whatThe ₹2.4 billion hit to the bottom line contributed to a single-day market cap loss of 9.4% on July 22.
More negative than 70% of claims this week
Which stocks this story touches
More negative than 90% of ticker scores this week
The company is under investigation for potential securities fraud following a significant stock price drop and production-related losses.
More negative than 80% of ticker scores this week
The company is being investigated by a law firm on behalf of investors.
More negative than 80% of ticker scores this week
The company is being investigated by a law firm on behalf of investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
2h ago
—
RDY hasn't traded since this ran. Last close $12.57 (Sep 22); the reaction starts at the next open.
RDY chart →
